The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

CVS Health's poor 2024 performance was driven by ... PBMs and MA plans are core to the CVS Caremark and Aetna insurance segments. But will the rhetoric stick? PBMs are an easy target.

CVS Caremark, Express Scripts ... based on a subset of medications that represent less than 2% of what our health plans spend on medications in a year.” Express Scripts sued the FTC in September ...

A GoLocal investigation explores how CVS and its then-President Helena Foulkes often told one story about opioids while the company profited, and she made tens of millions in salary, stock incentives, ...

Eli Lilly, Novo Nordisk, CVS Health, CVS Pharmacy, Caremark Health, United Health Group, Express Scripts Pharmacy and more are named in the lawsuit, accused of managing a pricing and kickback ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...